Stockreport

Wall Street Analysts See an 113.71% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? [Yahoo! Finance]

Benitec Biopharma Inc.  (BNTC) 
US:NASDAQ Investor Relations: benitec.com/for-investors/investor-faqs
PDF upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $24 indicates an 113.7% upside potential. The [Read more]